1st Quarter - Report
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
Income
—
Expenses
$790,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
42 CFR Part 2, Kidney Health, Mental Health
| Lobbyist | Covered position, as disclosed |
|---|---|
| THADDEUS FLOOD New | — |
| ORKIDEH MALKOC | — |
| MOLLY RYAN | — |
Medicare/Medicaid MMM
Mental Health Policy, Renal Care Policy, Drug Pricing (H.R.3, SFC bill PDPRA, Drug Pricing (H.R.3, SFC bill PDPRA), Medicare Part D Redesign
| Lobbyist | Covered position, as disclosed |
|---|---|
| THADDEUS FLOOD New | — |
| ORKIDEH MALKOC | — |
| MOLLY RYAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.